Methodologies in biosimilar product development / edited by Sang Joon Lee, Shein-Chung Chow.

Other author Lee, Sang Joon.
Other author Chow, Shein-Chung, 1955-
Format Electronic
EditionFirst edition.
Publication InfoBoca Raton : CRC Press/Taylor & Francis Group, 2022.
Descriptionxii, 380 pages: illustrations ; 24 cm
Supplemental ContentFull text available from Taylor & Francis eBooks
Subjects

SeriesChapman & Hall/CRC biostatistics series
Abstract "Methodologies for Biosimilar Product Development covers the practical and challenging issues that are commonly encountered during the development, review, and approval of a proposed biosimilar product. These practical and challenging issues include, but are not limited to the mix-up use of interval hypotheses testing (i.e., the use of TOST) and confidence interval approach, a risk/benefit assessment for non-inferiority/similarity margin, PK/PD bridging studies with multiple references, the detection of possible reference product change over time, design and analysis of biosimilar switching studies, the assessment of sensitivity index for assessment of extrapolation across indications without collecting data from those indications not under study, and the feasibility and validation of non-medical switch post-approval"-- Provided by publisher.
Bibliography noteIncludes bibliographical references and index.
Access restrictionAvailable only to authorized users.
Technical detailsMode of access: World Wide Web
Genre/formElectronic books.
LCCN 2021021525
ISBN9780367896348 (hardback)
ISBN9781032071800 (paperback)
ISBN(ebook)

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available